SEMAX
Semax is a nootropic and neuroprotective peptide originally developed in Russia. Research has explored its effects on memory, attention and neurological recovery, with particular interest in its influence on brain plasticity and BDNF signalling.
SEMAX — QUICK SUMMARY
What is Semax?
Semax is a synthetic seven-amino-acid peptide derived from a short fragment of adrenocorticotropic hormone (ACTH). Unlike ACTH itself, Semax is primarily studied for its effects involving the brain rather than for stimulating adrenal hormone production.
It was developed and studied extensively in Russia, where researchers investigated its effects on attention, cognitive performance and recovery after reduced blood flow to the brain during ischemic stroke.
One of the main areas of interest is neuroplasticity — the brain’s ability to adapt, form and strengthen connections and respond to learning or injury. Semax has been studied for its influence on neurotrophic signalling, including pathways involving brain-derived neurotrophic factor (BDNF).
Most human clinical research on Semax is not about productivity or everyday cognitive enhancement. Much of the meaningful human research has investigated neurological conditions such as ischemic stroke and recovery.
Community Discussion
See what the Supp Science community is discussing about Semax.
Semax discussions are on the way
Community threads and discussions about Semax will appear here as they are added to Supp Science.